C

메타케어

118000KOSPI기계장비 및 관련 물품 도매업

51.0 / 100

Reference Date: 2026-07-24

Financial Score10.5 / 40
News Sentiment12.5 / 25
Momentum16.0 / 20
Disclosure12.0 / 15
AI Analysis: PBR is significantly undervalued vs. peers but the high debt ratio poses financial risk. Rose 8.5% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

MetaCare operates across four business segments: Pharmaceuticals, Medical, Investment, and Real Estate Development, with the Pharmaceuticals segment contributing 77.2% of total revenue. The company has expanded its market presence through acquisitions, such as J&N Pharm and H Bio&Co, and achieved 2.8% revenue share from Real Estate Development in 2024.

Number of Employees

32people

Average Salary

65.7M KRW

Score Calculation Basis

Detailed Financial Score

PER
451.67Industry Average 8.650.0Point

52.2x industry avg (risky)

PBR
0.25Industry Average 0.587.0Point

Half of industry avg (excellent)

ROE
-0.18Industry Average 2.780.0Point

Well below industry avg

Debt Ratio
20.74Industry Average 6.760.0Point

3.1x industry avg (risky)

Trend 2023~20253.5 / 10 points
Revenue Growth Rate
0.5 / 3

Avg ▼0.7% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲52.5% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -4.3% (improving, 3yr)

Detailed News Sentiment

2 totalPositive 0Neutral 2Negative 0Average Sentiment Score 50

Detailed Momentum

52-week position6.0Point

52w upper range (67%)

Current 1,355Won52-week high 1,90952-week low 208
1-month return5.0Point

1m +8.49% (rising)

Volume trend5.0Point

Volume increasing

Detailed Disclosure

5 totalPositive 1Neutral 4Negative 0
  • Neutral기타안내사항(안내공시)2026-07-08
  • Positive[기재정정]주요사항보고서(유상증자결정)2026-06-29
  • Neutral타법인주식및출자증권취득결정2026-06-29
  • Neutral주식등의대량보유상황보고서(일반)2026-06-29
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-29